dr. Zakaria Aulia Rahman, Sp.U., M. Ked. Klin

Jadwal dr. Zakaria Aulia Rahman, Sp.U., M. Ked. Klin

Jadwalkan Pertemuan

Bedah Urologi

specialized in General Urologic

Pendidikan dr. Zakaria Aulia Rahman, Sp.U., M. Ked. Klin

Bachelor of Medicine, Medical Faculty, Diponegoro University, Semarang, Indonesia
Medical Doctor, Medical Faculty, Diponegoro University, Semarang, Indonesia
Master of Clinical Medicine (Combined Degree), Medical Faculty, Airlangga University, Surabaya, Indonesia
Urology Specialist, medical faculty, Airlangga University, Surabaya, Indonesia
Clinical Observership and training for Bladder Cancer management and Urinary Diversion at Urology-Nephrology center Mansoura University, Egypt
Fellowship in Urology-Oncology Bladder cancer management at Dr. Soetomo General Hospital (Continuing)

Bachelor of Medicine, Medical Faculty, Diponegoro University, Semarang, Indonesia
Medical Doctor, Medical Faculty, Diponegoro University, Semarang, Indonesia
Master of Clinical Medicine (Combined Degree), Medical Faculty, Airlangga University, Surabaya, Indonesia
Urology ...

Pengalaman Pelatihan dr. Zakaria Aulia Rahman, Sp.U., M. Ked. Klin

Symposium Recover together to Improve Urology Practice Skill The 40th Fiesta Urology 2023
Webinar Scientific Writing and Publishing Global Andrology Forum 2023
Symposium The 41th Fiesta Urology 2024
Symposium UAA-ASMIUA 2024
Symposium The 42nd Fiesta Urology 2025
Basic Laparoscopy Workshop for Urology The 42nd Fiesta Urology 2025
19th Training Course on Bladder Cancer and Urinary Diversion (from A-Z), Mansoura Urology nephrology center Egypt

Symposium Recover together to Improve Urology Practice Skill The 40th Fiesta Urology 2023
Webinar Scientific Writing and Publishing Global Andrology Forum 2023
Symposium The 41th Fiesta Urology 2024
Symposium UAA-ASMIUA ...

Organisasi

Media Publikasi

with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical

prognostic factors in advanced/metastatic urothelial carcinoта

Session, The 42th Fiesta Urology 2025

42th Fiesta Urology 2025

2025

growth inhibition by silodosin and abiraterone acetate in PC-3 human prostate cancer

cells

with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical